Literature DB >> 30644095

A dynamic reversible RNA N6 -methyladenosine modification: current status and perspectives.

Zhen Bi1, Youhua Liu1, Yuanling Zhao1, Yongxi Yao1, Ruifan Wu1, Qing Liu1, Yizhen Wang1, Xinxia Wang1.   

Abstract

N6 -methyladenosine (m6 A), as the most abundant RNA epigenetic modifications, has been shown to play critical roles in various biological functions. Research about enzymes that can catalyze and remove m6 A have revealed its comprehensive roles in messenger RNA (mRNA) metabolism and other physiological processes. The "readers" including YTH domain-containing proteins, hnRNPC, hnRNPG, hnRNPA2B1, IGF2BP1, IGF2BP2, and IGF2BP3, which can affect the fates of mRNA in an m6 A-dependent manner. In this review, we focus on recent advances in the research of the m6 A modifications, especially about the latest functions of its writers, erasers, readers in RNA metabolism, cancer, and lipid metabolism. In the end, we provide insights into the underlying molecular mechanisms of m6 A modifications.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  demethylases; m6A; mRNA methylation; methyltransferases

Mesh:

Substances:

Year:  2019        PMID: 30644095     DOI: 10.1002/jcp.28014

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population.

Authors:  Pingting Ying; Yao Li; Nan Yang; Xiaoyang Wang; Haoxue Wang; Heng He; Bin Li; Xiating Peng; Danyi Zou; Ying Zhu; Rong Zhong; Xiaoping Miao; Jianbo Tian; Jiang Chang
Journal:  Arch Toxicol       Date:  2021-01-21       Impact factor: 5.153

2.  N6-methyladenosine mediates arsenite-induced human keratinocyte transformation by suppressing p53 activation.

Authors:  Tianhe Zhao; Donglei Sun; Manyu Zhao; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Pollut       Date:  2020-01-07       Impact factor: 8.071

3.  Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.

Authors:  Jingchao Liu; Wei Zhang; Jiawen Wang; Zhengtong Lv; Haoran Xia; Zhipeng Zhang; Yaoguang Zhang; Jianye Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-22       Impact factor: 4.553

4.  N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1.

Authors:  Zili Zhang; Yu Xing; Wenqing Gao; Liping Yang; Junzhong Shi; Weiliang Song; Tong Li
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  Genome-wide identification and characterization of YTH domain-containing genes, encoding the m6A readers, and their expression in tomato.

Authors:  Shuangqin Yin; Qiujing Ao; Caiyun Tan; Yingwu Yang
Journal:  Plant Cell Rep       Date:  2021-06-03       Impact factor: 4.570

6.  m6 A modification of HSATIII lncRNAs regulates temperature-dependent splicing.

Authors:  Kensuke Ninomiya; Junichi Iwakiri; Mahmoud Khamis Aly; Yuriko Sakaguchi; Shungo Adachi; Tohru Natsume; Goro Terai; Kiyoshi Asai; Tsutomu Suzuki; Tetsuro Hirose
Journal:  EMBO J       Date:  2021-06-29       Impact factor: 14.012

Review 7.  A Census and Categorization Method of Epitranscriptomic Marks.

Authors:  Julia Mathlin; Loredana Le Pera; Teresa Colombo
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 8.  Significant epitranscriptomes in heterogeneous cancer.

Authors:  Masamitsu Konno; Masateru Taniguchi; Hideshi Ishii
Journal:  Cancer Sci       Date:  2019-08       Impact factor: 6.716

9.  Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.

Authors:  Zhen Zhang; Quan Wang; Mengmeng Zhang; Wei Zhang; Long Zhao; Changjiang Yang; Bo Wang; Kewei Jiang; Yingjiang Ye; Zhanlong Shen; Shan Wang
Journal:  Epigenetics       Date:  2020-08-12       Impact factor: 4.528

10.  Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer.

Authors:  Xinyi Wang; Xiaorui Fu; Junjia Zhang; Chengfeng Xiong; Shuyong Zhang; Yunxia Lv
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.